GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hamilton Thorne Ltd (TSX:HTL) » Definitions » Price-to-Free-Cash-Flow

Hamilton Thorne (TSX:HTL) Price-to-Free-Cash-Flow : 347.50 (As of May. 20, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Hamilton Thorne Price-to-Free-Cash-Flow?

As of today (2024-05-20), Hamilton Thorne's share price is C$1.39. Hamilton Thorne's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was C$0.00. Hence, Hamilton Thorne's Price-to-Free-Cash-Flow Ratio for today is 347.50.

The historical rank and industry rank for Hamilton Thorne's Price-to-Free-Cash-Flow or its related term are showing as below:

TSX:HTL' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 10   Med: 34.33   Max: 1380
Current: 347.5

During the past 13 years, Hamilton Thorne's highest Price-to-Free-Cash-Flow Ratio was 1380.00. The lowest was 10.00. And the median was 34.33.

TSX:HTL's Price-to-Free-Cash-Flow is ranked worse than
97.3% of 333 companies
in the Medical Devices & Instruments industry
Industry Median: 34.4 vs TSX:HTL: 347.50

Hamilton Thorne's Free Cash Flow per Share for the three months ended in Mar. 2024 was C$-0.01. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was C$0.00.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -62.80% per year.

During the past 13 years, Hamilton Thorne's highest 3-Year average Free Cash Flow per Share Growth Rate was 101.40% per year. The lowest was -62.80% per year. And the median was 26.00% per year.


Hamilton Thorne Price-to-Free-Cash-Flow Historical Data

The historical data trend for Hamilton Thorne's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hamilton Thorne Price-to-Free-Cash-Flow Chart

Hamilton Thorne Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.22 35.90 68.67 - 665.00

Hamilton Thorne Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 181.25 - 665.00 325.00

Competitive Comparison of Hamilton Thorne's Price-to-Free-Cash-Flow

For the Medical Devices subindustry, Hamilton Thorne's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hamilton Thorne's Price-to-Free-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hamilton Thorne's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Hamilton Thorne's Price-to-Free-Cash-Flow falls into.



Hamilton Thorne Price-to-Free-Cash-Flow Calculation

Hamilton Thorne's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=1.39/0.004
=347.50

Hamilton Thorne's Share Price of today is C$1.39.
Hamilton Thorne's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Hamilton Thorne  (TSX:HTL) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Hamilton Thorne Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Hamilton Thorne's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Hamilton Thorne (TSX:HTL) Business Description

Traded in Other Exchanges
Address
100 Cummings Center, Suite 465E, Beverly, MA, USA, 01915
Hamilton Thorne Ltd is engaged in providing precision instruments, consumables, software, and services that reduce cost, increase productivity, improve results, and enable breakthroughs in Assisted Reproductive Technologies (ART) and developmental biology research markets. The company markets its products and services under the Hamilton Thorne, Gynemed, and Embryotech Laboratories brands, through its growing sales force and distributors. The company's customer base consists of fertility clinics, university research centers, animal breeding facilities, pharmaceutical companies, biotechnology companies, and other commercial and academic research establishments. It has a single reporting segment being Engaged in Sales to the ART, Research, and Cell Biology Markets.
Executives
Robert J Potter Director

Hamilton Thorne (TSX:HTL) Headlines

No Headlines